AA Medical Names New CEO

AA Medical is under new management. The tech-enabled solutions provider of medical equipment and supplies has appointed Jay Burkhardt as CEO.

Burkhardt succeeds former CEO Matt Nelson, who’s had the job since 2012 and will now become chief technology officer, overseeing the company’s continued development of its technology solutions, marketing efforts, and equipment acquisition strategy. “With the significant growth of our business over the recent years, we are entering the next phase of evolution of our company. Jay’s track record of experience across healthcare and his approach to building high-performing teams in parallel verticals will be hugely impactful at AA Medical as we look to maximize our impact and extend our reach,” Nelson said.

Burkhardt joins AA Medical from Probo Medical, a private equity-backed global diagnostic imaging solutions provider, where he most recently worked as president and chief operating officer. He was hired at Probo Medical in 2019 and led the business through multiple phases of transformational growth. Prior to Probo Medical, Burkhardt spent nearly 10 years with McKesson and its subsidiary, US Oncology, in various leadership roles that spanned commercial, operations, strategy, and M&A.

Burkhardt earned his bachelor’s degree from DePauw University, his MBA from Thunderbird School of Global Management and Oklahoma State University, and a Certificate in Mergers and Acquisitions from the Wharton School at the University of Pennsylvania.

“I am excited to join AA Medical team and to continue building upon the foundation that’s been established to create a differentiated medical equipment and supplies company,” Burkhardt stated. “AA Medical has built a unique value proposition in the medical equipment and supplies space. Our solutions center on leveraging technology to cultivate and connect a global network of buyers and sellers, while also pushing on cutting-edge models that simultaneously extend the life of medical equipment and supplies and return value back to healthcare facilities. I look forward to continuing to build upon the success at AA Medical with the team, our partners at Shore Capital, and our Board of Directors.”

AA Medical is backed by Shore Capital Partners, a private equity firm with deep expertise across the healthcare sector. “We are greatly appreciative to Matt Nelson for his countless contributions to AA Medical. The growth and transformation of AA Medical since our initial investment under his leadership has been tremendous,” commented Don Pierce, Shore Capital Partner’s lead partner on the investment in AA Medical. “As AA Medical enters its next phase of growth, we are excited to bring on Jay Burkhardt as CEO to continue to develop the platform. We have known Jay for a number of years and believe his background, skill set, and track record will be hugely impactful to the business.”

Founded in 2012, AA Medical provides sustainable solutions to the medical equipment and supplies markets with a concentration in new and pre-owned endoscopic, orthopedic, and other surgical devices. Through its proprietary technology, AA Medical engages with healthcare facilities to unlock residual value and maximize return from unneeded medical equipment and supplies. AA Medical’s technology-enabled solutions connect buyers and sellers with re-deployed medical equipment and supplies, backed with the quality promise of AA Medical’s reprocessing, repair, and refurbishment expertise.

Chicago-based Shore Capital is an investor in lower middle market companies in the healthcare, food and beverage, business services, industrial, and real estate industries. Shore’s strategy is to support management partners to grow faster with less risk through access to capital, board and operational resources, and networking, development, and shared learnings across the portfolio. From 2020-2024, Shore was recognized by Inc Magazine as a 5x Top Founder Friendly Investor and by Pitchbook Research for being the global leader in private equity total deal volume from 2019-2023. Shore targets investments in proven, successful private companies with superior management teams, stable cash flow, and significant potential to grow through industry consolidation and organic growth to generate value for shareholders. Shore has approximately $11.5 billion of assets under management and in additional investment platforms to which it provides business and operational consulting services.